Overview

A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the efficacy and safety of a single dose of intravenous peramivir versus placebo in adolescents and adults with acute uncomplicated influenza.
Phase:
Phase 3
Details
Lead Sponsor:
BioCryst Pharmaceuticals
Collaborator:
Department of Health and Human Services
Treatments:
Peramivir